0.184USD+0.184盤後交易 07/31, 20:00 (美東)
關鍵數據
0.186今開
0.194最高
900.94K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
13.77%換手率
0.189昨收
0.183最低
77.53K成交額
虧損本益比靜
-0.06市淨率
0.00%股息率 TTM
-147.70%ROA
14.71252週最高
0.28量比
-17.73M淨利潤
6.54M總股本
-22.1939每股盈餘TTM
1.25Beta
-672.21%ROE
0.36152週最低
5.93%振幅
--毛利率
1.22M總市值
-4.56回報/風險
8.95%風險率
Biomx Inc新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
Ionis Pharmaceuticals Inc
IONS
25
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
Biomx Inc簡介
BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).
公司代碼PHGE
公司Biomx Inc
CEOSolomon (Jonathan Eitan)
網址https://www.biomx.com/
公司股東
常見問題
Biomx Inc(PHGE)的當前股價是多少?
Biomx Inc(PHGE)的當前股價是 0.19。
Biomx Inc股票的52週最高點是14.71。
現在Biomx Inc(PHGE)的股票是買入、持有還是賣出?
根據分析師評級,Biomx Inc(PHGE)的總體評級為signal_hold,目標價格為26.00。
Biomx Inc(PHGE)股票的每股收益(EPS TTM)是多少
Biomx Inc(PHGE)股票的每股收益(EPS TTM)是-22.19。